TY - JOUR
T1 - Management of hepatocellular carcinoma in Japan
T2 - Consensus-based clinical practice guidelines proposed by the Japan society of hepatology (JSH) 2010 updated version
AU - Kudo, Masatoshi
AU - Izumi, Namiki
AU - Kokudo, Norihiro
AU - Matsui, Osamu
AU - Sakamoto, Michiie
AU - Nakashima, Osamu
AU - Kojiro, Masamichi
AU - Makuuchi, Masatoshi
PY - 2011/8
Y1 - 2011/8
N2 - Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.
AB - Hepatocellular carcinoma (HCC) is one of the leading causes of cancer death not only in Japan but also worldwide. Clinical practice guidelines for HCC were first published in 2001 by the European Society of Study of the Liver (EASL) followed by the American Association for the Study of Liver Disease (AASLD) published in 2005 and updated in 2010. However, these guidelines have proven to be somewhat unsuitable for Japanese patients. In 2005, supported by the Japanese Ministry of Health, Labour and Welfare, evidence-based clinical practice guidelines for HCC were compiled in Japan. In 2009, a revised version of evidence-based guidelines was published. Based on both 'evidence-based' guidelines and the consensus of an expert panel on HCC, the Japan Society of Hepatology (JSH) published the Consensus-Based Clinical Practice Manual in 2007 and updated in 2010. In this article, the 2010 updated version of this manual, especially issues on prevention, surveillance, pathology, diagnosis, staging, and treatment algorithm are summarized.
KW - Clinical practice guidelines
KW - Clinical practice manual
KW - Consensus-based
KW - Diagnostic algorithm
KW - Evidence-based
KW - Hepatocellular carcinoma
KW - Prevention
KW - Staging
KW - Surveillance
KW - Treatment algorithm
UR - http://www.scopus.com/inward/record.url?scp=80051758429&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=80051758429&partnerID=8YFLogxK
U2 - 10.1159/000327577
DO - 10.1159/000327577
M3 - Article
C2 - 21829027
AN - SCOPUS:80051758429
VL - 29
SP - 339
EP - 364
JO - Digestive Diseases
JF - Digestive Diseases
SN - 0257-2753
IS - 3
ER -
